Research Diagnosis Related Groups (DRG) level LOS quality outcomes for DCH Regional Medical Center located at 809 University Blvd E, Tuscaloosa, AL, 35401 & includes data from NPIs 1780927681, 1841394418
Dexur analyzed Q1 2017 (January to March 2017) Medicare claims data to benchmark length of stay (LOS) outcomes for DCH Regional Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,910 | 2,772 | ||||||||||
| Surgical | 781 | 753 | ||||||||||
| Non Surgical | 2,129 | 2,019 | ||||||||||
| Cardiovascular | 624 | 599 | ||||||||||
| Pulmonology | 466 | 440 | ||||||||||
| General Medicine | 341 | 304 | ||||||||||
| Gastroenterology & Endocrinology | 319 | 309 | ||||||||||
| Orthopedics | 300 | 292 | ||||||||||
| Neurology | 228 | 218 | ||||||||||
| Urology | 209 | 206 | ||||||||||
| General Surgery | 196 | 183 | ||||||||||
| Oncology & Hematology | 78 | 76 | ||||||||||
| Spine | 44 | 44 | ||||||||||
| Psychiatry & Mental Disorders | 39 | 38 | ||||||||||
| Colorectal | 35 | 35 | ||||||||||
| Obstetrics & Gynecology | 17 | 16 |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| Hypertension | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Percutaneous Cardiovascular Procedures Without Coronary Artery Stent | ||||||||||||
| Other Major Cardiovascular Procedures |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 203: BRONCHITIS AND ASTHMA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Embolism |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 639: DIABETES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cholecystectomy | ||||||||||||
| DRG 417: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||
| DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Other Kidney And Urinary Tract Procedures |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
| Extracranial Procedures |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Spinal Fusion | ||||||||||||
| DRG 473: CERVICAL SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Jan 2017 to Mar 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Alabama Total Hospitalizations (Jan 2017 to Mar 2017) | Alabama Total Hospitalizations After Exclusion | Alabama Total Users | Alabama Avg. LOS | National Total Hospitalizations (Jan 2017 to Mar 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |